UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 15-12G
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
 
 
Commission File Number
000-51905
 
 
OMRIX BIOPHARMACEUTICALS, INC.
 
(Exact name of registrant as specified in its charter)
 
Omrix Biopharmaceuticals, Inc.
1120 Avenue of Americas
New York, New York 10036
(212) 887-6500
 
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, par value $0.01 per share
 
(Title of each class of securities covered by this Form)
 
None
 
(Titles of all other classes of securities for which a duty to file reports under
section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)
x
 
 
Rule 12g-4(a)(2)
o
 
 
Rule 12h-3(b)(1)(i)
x
 
 
Rule 12h-3(b)(1)(ii)
o
 
 
Rule 15d-6
o
 
 
Approximate number of holders of record as of the certification or notice date: 1
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Omrix Biopharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date:  December 30, 2008
By:
/s/ James J. Bergin
 
 
Name:
James J. Bergin
 
 
Title:
Vice President
 
 

 
 
Instruction:  This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934.  The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed.  It may be signed by an officer of the registrant, by counsel or by any other duly authorized person.  The name and title of the person signing the form shall be typed or printed under the signature.
Omrix Biopharmaceuticals (MM) (NASDAQ:OMRI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Omrix Biopharmaceuticals (MM) Charts.
Omrix Biopharmaceuticals (MM) (NASDAQ:OMRI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Omrix Biopharmaceuticals (MM) Charts.